Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Pharmacological interventions for managing acute pancreatitis
The prevalence of acute pancreatitis is between 5 and 30 per 100,000 population worldwide. It also represents the most common cause for gastrointestinal hospital...
Beware the risk of drug-associated heat stroke in the elderly
A 76-year-old man with past medical history significant for a cerebrovascular accident, pacemaker insertion for sick sinus syndrome and transurethral resection for benign prostatic...
The startling extent of Australia’s medication overuse
A new report has found that Australians continue to overuse certain medicines. Pharmacist intervention is necessary to keep this issue in check, said the...
Pharmacists in 2023 – unlocking the future of pharmacy
A major new PSA report, Pharmacists in 2023, reveals a roadmap for the changes needed to ensure the profession’s potential is realised – and...
Nasal swab offers hope for reducing vancomycin use
A study has found a pharmacy-driven protocol using nasal swabs to assess methicillin‑resistant Staphylococcus aureus (MRSA) in pneumonia cases holds promise for reducing unnecessary...
Antimicrobial use up in disadvantaged areas
Antimicrobial medicines use declined in Australia from 2013 to 2018, but the country’s rate remains high by OECD standards, according to new research.
